Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
Статья

GATE: a simulation toolkit for PET and SPECT

S JanService Hospitalier Frédéric Joliot, CEA, F-91401 Orsay, FranceG. SantinLPHE, Swiss Federal Institute of Technology (EPFL), CH-1015 Lausanne, SwitzerlandD. StrulLPHE, Swiss Federal Institute of Technology (EPFL), CH-1015 Lausanne, SwitzerlandSteven StaelensELIS, Ghent University, B-9000 Ghent, BelgiumKarine AssiéINSERM U494, CHU Pitié-Salpêtrière, F-75634 Paris, FranceD. AutretINSERM U601, CHU Nantes, F-44093 Nantes, FranceStéphane AvnerInstitut de Recherches Subatomiques, CNRS/IN2P3 et Université Louis Pasteur, F-67037 Strasbourg, FranceR. BarbierInstitut de Physique Nucléaire de Lyon, CNRS/IN2P3 et Université Claude Bernard, F-69622 Villeurbanne, FranceManuel BardièsINSERM U601, CHU Nantes, F-44093 Nantes, FranceP BloomfieldPET Group, Centre for Addiction and Mental Health, Toronto, Ontario M5T 1R8, CanadaD. BrasseInstitut de Recherches Subatomiques, CNRS/IN2P3 et Université Louis Pasteur, F-67037 Strasbourg, FranceVincent BretonLaboratoire de Physique Corpusculaire, CNRS/IN2P3, Université Blaise Pascal, Campus des Cézeaux, F-63177 Aubière, FranceP. BruyndonckxInter-University Institute for High Energies, Vrije Universiteit Brussel, B-1050 Brussel, BelgiumIrène BuvatINSERM U494, CHU Pitié-Salpêtrière, F-75634 Paris, FranceArion F. ChatziioannouCrump Institute for Molecular Imaging, University of California, Los Angeles, CA 90095-1770, USAYong ChoiDepartment of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 135-710, KoreaYong Hyun ChungDepartment of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 135-710, KoreaClaude ComtatService Hospitalier Frédéric Joliot (SHFJ), CEA, F-91401 Orsay, FranceD. DonnarieixDépartement de Curiethérapie-Radiothérapie, Centre Jean Perrin, F-63000 Clermont-Ferrand, FranceLudovic FerrerINSERM U601, CHU Nantes, F-44093 Nantes, FranceStephen J. GlickUniversity of Massachusetts Medical School, Division of Nuclear Medicine, Worcester, MA 01655, USAC.J. GroiselleUniversity of Massachusetts Medical School, Division of Nuclear Medicine, Worcester, MA 01655, USADavid GuezDAPNIA, CEA Saclay, F-91191 Gif-Sur-Yvette, FranceP-F HonoreDAPNIA, CEA Saclay, F-91191 Gif-Sur-Yvette, FranceS Kerhoas-CavataDAPNIA, CEA Saclay, F-91191 Gif-Sur-Yvette, FranceAssen S. KirovDepartment of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USAV. KohliCrump Institute for Molecular Imaging, University of California, Los Angeles, CA 90095-1770, USAMichel KooleELIS, Ghent University, B-9000 Ghent, BelgiumM. KrieguerInter-University Institute for High Energies, Vrije Universiteit Brussel, B-1050 Brussel, BelgiumD.J. van der LaanDelft University of Technology, IRI, Radiation Technology, 2629 JB Delft, The NetherlandsF. LamareINSERM U650, Laboratoire de Traitement de l'Information Médicale (LATIM), CHU Morvan, F-29609 Brest, FranceG. LargeronInstitut de Physique Nucléaire de Lyon, CNRS/IN2P3 et Université Claude Bernard, F-69622 Villeurbanne, FranceCarole LartizienANIMAGE-CERMEP, Université Claude Bernard Lyon 1, F-69003 Lyon, FranceD. LazaroLaboratoire de Physique Corpusculaire, CNRS/IN2P3, Université Blaise Pascal, Campus des Cézeaux, F-63177 Aubière, FranceMarnix C. MaasDelft University of Technology, IRI, Radiation Technology, 2629 JB Delft, The NetherlandsLydia MaigneLaboratoire de Physique Corpusculaire, CNRS/IN2P3, Université Blaise Pascal, Campus des Cézeaux, F-63177 Aubière, FranceF. MayetLaboratoire de Physique Subatomique et de Cosmologie, CNRS/IN2P3 et Université Joseph Fourier, F-38026 Grenoble, FranceF. MelotLaboratoire de Physique Subatomique et de Cosmologie, CNRS/IN2P3 et Université Joseph Fourier, F-38026 Grenoble, FranceCharbel MerhebDAPNIA, CEA Saclay, F-91191 Gif-Sur-Yvette, FranceE. PennacchioInstitut de Physique Nucléaire de Lyon, CNRS/IN2P3 et Université Claude Bernard, F-69622 Villeurbanne, FranceJ PerezInstitute of Medicine, Forschungszemtrum Juelich, D-52425 Juelich, GermanyU. PietrzykInstitute of Medicine, Forschungszemtrum Juelich, D-52425 Juelich, GermanyFernando R. RannouCrump Institute for Molecular Imaging, University of California, Los Angeles, CA 90095-1770, USAM. ReyLPHE, Swiss Federal Institute of Technology (EPFL), CH-1015 Lausanne, SwitzerlandDennis R. SchaartDelft University of Technology, IRI, Radiation Technology, 2629 JB Delft, The NetherlandsC. Ross SchmidtleinDepartment of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USAL. SimonLPHE, Swiss Federal Institute of Technology (EPFL), CH-1015 Lausanne, SwitzerlandT. Y. SongDepartment of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 135-710, KoreaJ-M VieiraLPHE, Swiss Federal Institute of Technology (EPFL), CH-1015 Lausanne, SwitzerlandDimitris VisvikisINSERM U650, Laboratoire de Traitement de l'Information Médicale (LATIM), CHU Morvan, F-29609 Brest, FranceRik Van de WalleELIS, Ghent University, B-9000 Ghent, BelgiumE. WieërsInter-University Institute for High Energies, Vrije Universiteit Brussel, B-1050 Brussel, BelgiumC. MorelLPHE, Swiss Federal Institute of Technology (EPFL), CH-1015 Lausanne, Switzerland
2004en
ABI

Аннотация

Monte Carlo simulation is an essential tool in emission tomography that can assist in the design of new medical imaging devices, the optimization of acquisition protocols and the development or assessment of image reconstruction algorithms and correction techniques. GATE, the Geant4 Application for Tomographic Emission, encapsulates the Geant4 libraries to achieve a modular, versatile, scripted simulation toolkit adapted to the field of nuclear medicine. In particular, GATE allows the description of time-dependent phenomena such as source or detector movement, and source decay kinetics. This feature makes it possible to simulate time curves under realistic acquisition conditions and to test dynamic reconstruction algorithms. This paper gives a detailed description of the design and development of GATE by the OpenGATE collaboration, whose continuing objective is to improve, document and validate GATE by simulating commercially available imaging systems for PET and SPECT. Large effort is also invested in the ability and the flexibility to model novel detection systems or systems still under design. A public release of GATE licensed under the GNU Lesser General Public License can be downloaded at http:/www-lphe.epfl.ch/GATE/. Two benchmarks developed for PET and SPECT to test the installation of GATE and to serve as a tutorial for the users are presented. Extensive validation of the GATE simulation platform has been started, comparing simulations and measurements on commercially available acquisition systems. References to those results are listed. The future prospects towards the gridification of GATE and its extension to other domains such as dosimetry are also discussed.

Перевод пока недоступен

Идентификаторы

Цитирования и источники

Цитирований: 2Использованных источников: 0